中草药

基于CiteSpace可视化图谱分析傣药肾茶的研究动态及热点

PDF下载

中草药 | 数据挖掘与循证医学 2026,57(9): 3508-3529

收起

中草药 |数据挖掘与循证医学 2026 , 57 (9) : 3508 -3529

基于CiteSpace可视化图谱分析傣药肾茶的研究动态及热点

全屏

张建¹, 徐云东¹, 肖妮沁¹, 晏和国¹, 杨千千¹, 陈冰冰², 曾三金², 解静³, 谢招虎³, 李兆福³

作者信息

通讯作者:

谢招虎

作者简介:

张建: 张建,博士研究生,研究方向为中西医结合防治骨与关节病。E-mail:17860503891@163.com

Analysis of research trends and hotspots of Dai medicine Clerodendranthus spicatus based on CiteSpace visual mapping

ZHANG Jian, XU Yundong, XIAO Niqin, YAN Heguo, YANG Qianqian, CHEN Bingbing, ZENG Sanjin, XIE Jing, XIE Zhaohu, LI Zhaofu

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.09.020

文章导航

摘要

收起

目的基于CiteSpace知识图谱对傣药肾茶Clerodendranthus spicatus的相关研究文献进行可视化分析，系统梳理近年研究动态，阐述研究热点及未来发展趋势，为肾茶的深入研究与应用提供参考。方法分别在中国知网（China National Knowledge Infrastructure，CNKI）和Web of Science（WOS）核心集中检索肾茶在中医药领域的中英文文献，检索时间跨度为1995年1月1日—2025年10月30日，将CNKI和WOS检索到的记录分别导入NoteExpress文献管理软件，通过软件自动比对及人工核查，剔除同一数据库内部的重复记录，按纳入与排除标准筛选文献。基于筛选后的文献数据集，利用CiteSpace和Microsoft Excel对发文量、发文作者、研究机构、国家分布、关键词等进行可视化图谱分析。此外，对排名前10位的中英文文献进行高被引文献分析。结果筛选后共纳入626篇文献，其中包括中文文献274篇，英文文献352篇；发文量总体呈波动式上升趋势。中英文文献发表量最多的作者分别为宋立群和Ismail Zhari，作者合作网络显示团队内部合作较为紧密，不同团队间联系有限；发文量最多的研究机构分别是中国医学科学院药用植物研究所云南分所和Universiti Sains Malaysia，核心机构来自中医药类研究院所与高校。马来西亚成为发文量最多的国家。关键词分析显示中文文献的研究热点主要为药材资源、传统应用、临床研究等方面；英文文献更侧重于化学成分分析、药理作用、数据挖掘、分子机制等方面；高被引文献分析表明，相关研究主要聚焦于化学成分与物质基础、药理作用及机制、制剂工艺和现代方法学创新、综合性研究进展等方面，基本形成“成分-药效-制剂”相互支撑的研究框架。结论肾茶在中医药领域的研究热度持续升高，其在防治肾病、类风湿关节炎、痛风、骨关节炎、肿瘤等相关疾病的药理机制与临床应用已成为热点。未来可通过整合系统药理学和多组学技术，加强作用机制探索，建立科学的质量控制与临床评价体系，促进肾茶现代化开发和成果产出，为肾茶研究与民族药创新提供参考。

关键词

肾茶 / 中医药 / CiteSpace / 文献计量学 / 知识图谱 / 可视化分析

Abstract

收起

Objective To perform a visualized bibliometric analysis of research on the Dai medicine Clerodendranthus spicatus in the field of traditional Chinese medicine based on the CiteSpace knowledge graph, systematically summarize recent research trends, clarify hotspots and future directions, and provide a reference for further development and application of C. spicatus. Methods Chinese and English literature on C. spicatus in traditional Chinese medicine was retrieved from China National Knowledge Infrastructure (CNKI) and the Web of Science (WOS) Core Collection from 1 January 1995 to 30 October 2025. Records from each database were imported into NoteExpress for automatic and manual de-duplication, and then screened according to predefined inclusion and exclusion criteria. Based on the final dataset, CiteSpace and Microsoft Excel were used to perform visual analyses of publication output, authors, institutions, country distribution and keywords. In addition, the top 10 most-cited Chinese and English articles were subjected to high-cited literature analysis. Results A total of 626 publications were included, comprising 274 Chinese and 352 English articles, with an overall fluctuating upward trend in annual output. The most productive authors were Song Liqun and Ismail Zhari. Co-authorship networks showed relatively close collaboration within research teams but limited cooperation between different teams. The most productive institutions were the Yunnan Branch of the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, and Universiti Sains Malaysia, with core institutions mainly being traditional Chinese medicine research institutes and universities. Malaysia was the most productive country. Keyword analysis indicated that Chinese studies mainly focused on medicinal resources, traditional uses and clinical research, whereas English literature emphasized phytochemical profiling, pharmacological activities, data mining and molecular mechanisms. High-cited literature analysis revealed that both Chinese and English classic studies chiefly concentrated on chemical constituents and material basis, pharmacological effects and mechanisms, preparation technology and modern methodological innovation, as well as research progress, collectively forming a “constituent-pharmacology-formulation” research framework. Conclusion Research on C. spicatus in the field of traditional Chinese medicine has shown sustained growth, with its pharmacological mechanisms and clinical applications in the prevention and treatment of kidney diseases, rheumatoid arthritis, gout, osteoarthritis, and cancer becoming major research hotspots. Future studies should integrate systems pharmacology and multi-omics technologies, strengthen mechanistic exploration, and establish scientific quality control and clinical evaluation systems, thereby promoting the modernization and innovative development of C. spicatus and providing a reference for research on this herb and other ethnic medicines.

Key words

Clerodendranthus spicatus (Thunb.) C. Y. Wu / traditional Chinese medicine / CiteSpace / bibliometrics / knowledge mapping / visual analysis

引用本文

张建, 徐云东, 肖妮沁, 晏和国, 杨千千, 陈冰冰, 曾三金, 解静, 谢招虎, 李兆福. 基于CiteSpace可视化图谱分析傣药肾茶的研究动态及热点. 中草药, 2026 , 57 (9) : 3508 -3529 . DOI: 10.7501/j.issn.0253-2670.2026.09.020

ZHANG Jian, XU Yundong, XIAO Niqin, YAN Heguo, YANG Qianqian, CHEN Bingbing, ZENG Sanjin, XIE Jing, XIE Zhaohu, LI Zhaofu. Analysis of research trends and hotspots of Dai medicine Clerodendranthus spicatus based on CiteSpace visual mapping[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (9) : 3508 -3529 . DOI: 10.7501/j.issn.0253-2670.2026.09.020

基金

收起

国家自然科学基金项目(82274462);国家自然科学基金项目(82575036);北京市自然科学基金项目(7232284);国家中医药管理局第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]1号);北京市中医药管理局北京中医药新时代125工程(京中医药科字[2025]2号);北京中医药大学第三附属医院精诚人才计划(京中三院人[2025]4号)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

李晓花,李海涛,聂曲,等.紫花肾茶与白花肾茶形态和质量的比较[J].中药材,2023,46(6):1381-1386.
张兰,周云,赵应红.浅析傣医对帕雅拢牛的认识[J].云南中医中药杂志,2021,42(9):92-96.
Kalusalingam A,Hasnu D N,Khan A,et al.An updated review of ethnobotany,ethnopharmacology,phytochemistry and pharmacological activities of Orthosiphon stamineus Benth.[J].Malays Appl Biol,2024,53(1):1-18.
Jiao X M,Jin Q,Zhu P F,et al.Clerodendranthus spicatus:A comprehensive review of the chemical constituents,pharmacology,quality control and clinical applications[J].Front Pharmacol,2025,16:1452797.
Xiao X,Wu F H,Wang B,et al.Clerodendranthus spicatus(Thunb.) water extracts reduce lipid accumulation and oxidative stress in the Caenorhabditis elegans[J].Int JMol Sci,2024,25(17):9655.
熊秀比,李光盈,袁捷,等.猫须草化学成分及其抗菌活性研究[J].中草药,2025,56(18):6521-6530.
洪霖,邹小燕,张禧燕,等.肾茶及其活性提取物治疗肾脏相关疾病现代研究进展[J].中草药,2022,53(24):7970-7979.
李毅鹏,潘争红,符毓夏,等.猫须草抗炎活性成分研究[J].广西植物,2022,42(9):1480-1486.
赵于惠,向诚,徐天瑞,等.肾茶的化学成分、药理活性和质量控制方法研究进展[J].天然产物研究与开发,2023,35(7):1247-1264.
Zhang Y Q,Fu Y,Ruan J Y,et al.Highly oxygenated diterpenoids in Clerodendranthus spicatus and their bioactivity,a review[J].Biochem Syst Ecol,2023,106:104580.
陈元惠,罗霄,廖婉,等.基于Cite Space可视化图谱分析香附的研究动态及热点[J].中草药,2025,56(5):1717-1730.
Abdul Aziz A H,Putra N R,Kong H,et al.Supercritical carbon dioxide extraction of sinensetin,isosinensetin,and rosmarinic acid from Orthosiphon stamineus leaves:Optimization and modeling[J].Arab J Sci Eng,2020,45(9):7467-7476.
Mamat H,Mohd Faizal A N,Mohd Amin S F,et al.Application of supercritical carbon dioxide extraction of bioactive compounds from cat’s whiskers leaves[J].Sep Sci Plus,2025,8(2):e70015.
Zhang J W,Li G X,Xie S D,et al.Metabolite profiling of Clerodendranthus spicatus by UHPLC-Q-orbitrap HRMSand evaluation of antioxidant and tyrosinase activation activities[J].Chem Biodivers,2025,22(11):e00156.
陆应彩,卯明霞,彭霞,等.肾茶总黄酮的含量测定[J].中国民族民间医药,2018,27(11):37-41.
Guo Y X,Xie X,Wang S J,et al.Total flavonoids from Clerodendranthus spicatus alleviate renal ischemiareperfusion injury via activation of the Nrf2/HO-1pathway[J].Bratislava Med J,2025,126(10):2532-2542.
陈小芳,马国需,黄真,等.傣药肾茶中水溶性酚酸类化学成分的研究[J].中草药,2017,48(13):2614-2618.
Tung N N,Tam L T,Anh D H,et al.Antimicrobial phenolic metabolites from the aerial parts of Orthosiphon aristatus[J].Phytochem Lett,2022,52:49-53.
蓝伦礼,范庆红,曹骋,等.傣药肾茶的迷迭香酸和咖啡酸含量测定及指纹图谱研究[J].中华中医药杂志,2017,32(6):2740-2745.
Suhaimi S H,Hasham R,Idris M K H,et al.Rosmarinic acid rich fraction from Orthosiphon aristatus (Blume)Miq.leaves induces apoptosis by inhibiting the rapamycin signalling pathway[J].Adv Tradit Med,2025,25(4):995-1005.
黄天卓,丁薇娜,张琳杰,等.HPLC法建立肾茶醇提液中熊果酸检测方法及其方法学验证[J].山东化工,2020,49(19):93-95.
Chen W D,Zhao Y L,Dai Z,et al.Bioassay-guided isolation of anti-inflammatory diterpenoids with highly oxygenated substituents from kidney tea(Clerodendranthus spicatus)[J].J Food Biochem,2020,44(12):e13511.
Chen W P,Jin G J,Xiong Y,et al.Rosmarinic acid downregulates NO and PGE2 expression via MAPK pathway in rat chondrocytes[J].J Cell Mol Med,2018,22(1):346-353.
Luo Y X,Gong X,Su Z C,et al.Isolation,structure modification,and anti-rheumatoid arthritis activity of isopimarane-type diterpenoids from Orthosiphon aristatus[J].J Enzyme Inhib Med Chem,2024,39(1):2296355.
Chen W D,Zhao Y L,Sun W J,et al.“Kidney tea”and its bioactive secondary metabolites for treatment of gout[J].J Agric Food Chem,2020,68(34):9131-9138.
Arthanari M,Poyil M M.Antibacterial,antifungal,antibiofilm and antioxidant properties of Orthosiphon stamineus Benth.:An in vitro analysis[J].Ann Phytomed Int J,2024,13(1):736-743.
Deipenbrock M,Scotti F,Mo B,et al.Seven-day oral intake of Orthosiphon stamineus leaves infusion exerts antiadhesive ex vivo activity against uropathogenic E.coli in urine samples[J].Planta Med,2023,89(8):778-789.
Asraf M H,Sani N S,Williams C D,et al.In situ biosynthesized silver nanoparticle-incorporated synthesized zeolite A using Orthosiphon aristatus extract for in vitro antibacterial wound healing[J].Particuology,2022,67:27-34.
Li Y,Wang J,Jiang J H,et al.The protective effects of Clerodendranthus spicatus (Thunb.) C.Y.Wu extract on oxidative stress induced by 2,2'-azo (2-methylpropamidine) dihydrochloride in HL-1 mouse cardiomyocytes[J].Front Cardiovasc Med,2022,9:984813.
Al-Dulaimi D W,Shah Abdul Majid A,M Baharetha H,et al.Anticlastogenic,antimutagenic,and cytoprotective properties of Orthosiphon stamineus ethanolic leaves extract[J].Drug Chem Toxicol,2022,45(2):641-650.
宋立群,桑永浩,贠捷.傣药治疗肾脏病的机理和药效[J].中国中西医结合肾病杂志,2023,24(12):1035-1038.
杨钧朝,史伟,潘明珍,等.肾茶治疗肾性血尿机制研究进展[J].辽宁中医药大学学报,2022,24(8):123-127.
Zhou Z,Niu H J,Bian M,et al.Kidney tea[Orthosiphon aristatus (Blume) Miq.] improves diabetic nephropathy via regulating gut microbiota and ferroptosis[J].Front Pharmacol,2024,15:1392123.
Wang Y,Li K W,Yan S Y,et al.Clerodendranthus spicatus[Orthosiphon aristatus (Blume) Miq.] maintains uric acid homeostasis via regulating gut microbiota and restrains renal inflammation in hyperuricemic nephropathy[J].Front Pharmacol,2024,15:1485861.
Wu S H,Yan M X,Liu J Y,et al.Clerodendranthus spicatus inhibits epithelial-mesenchymal transition of renal tubular cells through the NF-κB/Snail signalling pathway in hyperuricaemia nephropathy[J].Pharm Biol,2023,61(1):1274-1285.
Xu W H,Wang H T,Sun Y,et al.Antihyperuricemic and nephroprotective effects of extracts from Orthosiphon stamineus in hyperuricemic mice[J].J Pharm Pharmacol,2020,72(4):551-560.
符静泉,郭为,韦曼莉,等.猫须草水提物对痛风性肾病大鼠肾脏URAT1、OAT1及病理的影响[J].中成药,2021,43(4):877-882.
符静泉,戴莉琳,韦曼莉,等.猫须草水提物对痛风性肾病大鼠的肾脏保护作用[J].中药材,2020,43(11):2785-2789.
郭银雪,胡茂蓉,葛平玉.肾茶黄酮对急性肾衰中肾小管上皮细胞保护作用的研究[J].世界科学技术-中医药现代化,2020,22(6):1773-1779.
郭银雪,葛平玉,胡茂蓉.肾茶黄酮通过ERK/CT-1通路治疗急性肾衰模型鼠氧化应激的实验研究[J].世界中医药,2020,15(18):2700-2703.
谢琴.肾茶对慢性肾炎患者肾小球内c4d沉积和血清肝细胞生长因子表达的影响[J].中国中西医结合肾病杂志,2018,19(7):604-606.
Li K W,Raza F,Jiang L D,et al.Clerodendranthus Spicatus:A review of its active compounds,mechanisms of action,and clinical studies in urinary diseases[J].Fitoterapia,2024,177:106082.
Arafat O M,Tham S Y,Sadikun A,et al.Studies on diuretic and hypouricemic effects of Orthosiphon stamineus methanol extracts in rats[J].J Ethnopharmacol,2008,118(3):354-360.
Adam Y,Somchit M N,Sulaiman M R,et al.Diuretic properties of Orthosiphon stamineus Benth.[J].JEthnopharmacol,2009,124(1):154-158.
Ambursa M B,Rahman M N G,Sulaiman S A,et al.An in vitro study of Orthosiphon stamineus (misai kucing)standardized water extract as a chemolytic agent in urolithiasis[J].J Pharm Bioallied Sci,2021,13(4):373-379.
张杰群,黄荣桂,郑兴中,等.肾茶提取物对小鼠三聚氰胺肾结石模型的影响[J].海峡药学,2021,33(10):4-7.
Chao Y F,Gao S Y,Li N,et al.Lipidomics reveals the therapeutic effects of Et OAc extract of Orthosiphon stamineus Benth.on nephrolithiasis[J].Front Pharmacol,2020,11:1299.
Dai S S,Fang Q,Li H Y,et al.Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of OATF against kidney stones[J].Front Pharmacol,2025,16:1575270.
袁小玲,龚志强,李本杰,等.基于TLR4/NF-κB/NLRP3通路探讨肾茶饮抗高尿酸血症的作用及机制[J].中药材,2024,47(5):1277-1281.
Zhou Z,Xu M F,Bian M,et al.Anti-hyperuricemia effect of Clerodendranthus spicatus:A molecular biology study combined with metabolomics[J].Sci Rep,2024,14:15449.
Yehya A H S,Subramaniam A V,Asif M,et al.Antitumour activity and toxicological studies of combination treatment of Orthosiphon stamineus and gemcitabine on pancreatic xenograft model[J].World J Gastroenterol,2022,28(32):4620-4634.
Yehya A H S,Asif M,Abdul Majid A M S,et al.Polymolecular botanical drug of Orthosiphon stamineus extract (C5OSEW5050ESA) as a complementary therapy to overcome gemcitabine resistance in pancreatic cancer cells[J].J Tradit Complementary Med,2023,13(1):39-50.
Ahamed M B K,Aisha A F A,Nassar Z D,et al.Cat’s whiskers tea (Orthosiphon stamineus) extract inhibits growth of colon tumor in nude mice and angiogenesis in endothelial cells via suppressing VEGFR phosphorylation[J].Nutr Cancer,2012,64(1):89-99.
Baharetha H M,Abdul Majid A M S,Nazari M V,et al.Optimised formulation and characterisation of liposomes for enhanced stability and antiproliferative efficacy of Orthosiphon aristatus var.aristatus extract in lung cancer treatment[J].Nat Prod Res,2025.doi:10.1080/14786419.2025.2494638.
龙贺明,罗艳,程海燕,等.肾茶总黄酮抗肾癌活性研究[J].赣南医学院学报,2017,37(2):179-184.
To D C,Hoang D T,Tran M H,et al.PTP1B inhibitory flavonoids from Orthosiphon stamineus Benth.and their growth inhibition on human breast cancer cells[J].Nat Prod Commun,2020,15:1934578X19899517.
Nguyen P T,Tran Huynh Q D,Nguyen M D.Isolation and purification of sinensetin,and in silico screening of phytochemicals from Orthosiphon aristatus (Blume) Miq.for anti-breast cancer activity[J].Nat Prod Res,2025:1-10.
Chung Y S,Choo B K M,Ahmed P K,et al.A systematic review of the protective actions of cat’s whiskers (misai kucing) on the central nervous system[J].Front Pharmacol,2020,11:692.
游建军,李光,李宇赤,等.肾茶总黄酮对帕金森病的神经保护作用[J].中国实验方剂学杂志,2015,21(4):139-143.
Chiang K H,Cheng T J,Kan W C,et al.Orthosiphon aristatus (Blume) Miq.Extracts attenuate Alzheimer-like pathology through anti-inflammatory,anti-oxidative,andβ-amyloid inhibitory activities[J].J Ethnopharmacol,2024,320:117132.
Retinasamy T,Shaikh M F,Kumari Y,et al.Orthosiphon stamineus standardized extract reverses streptozotocininduced Alzheimer’s disease-like condition in a rat model[J].Biomedicines,2020,8(5):104.
Choo B K M,Kundap U P,Kumari Y,et al.Orthosiphon stamineus leaf extract affects TNF-α and seizures in a zebrafish model[J].Front Pharmacol,2018,9:139.
Chung Y S,Choo B K M,Ahmed P K,et al.Orthosiphon stamineus proteins alleviate pentylenetetrazol-induced seizures in zebrafish[J].Biomedicines,2020,8(7):191.
Wang Q R,Wang J,Li N N,et al.A systematic review of Orthosiphon stamineus Benth.in the treatment of diabetes and its complications[J].Molecules,2022,27(2):444.
Bassalat N,Kadan S,Melamed S,et al.In vivo and in vitro antidiabetic efficacy of aqueous and methanolic extracts of Orthosiphon stamineus Benth.[J].Pharmaceutics,2023,15(3):945.
Abdullah F I,Chua L S,Mohd Bohari S P,et al.Rationale of Orthosiphon aristatus for healing diabetic foot ulcer[J].Nat Prod Commun,2020,15(9):1934578X20953308.
Alshehade S A,Al Zarzour R H,Murugaiyah V,et al.Mechanism of action of Orthosiphon stamineus against non-alcoholic fatty liver disease:Insights from systems pharmacology and molecular docking approaches[J].Saudi Pharm J,2022,30(11):1572-1588.
Cai X,Zhu L H,Yin X F,et al.The protective effects of Orthosiphon stamineus extract against intestinal barrier injury in high-fat diet-induced mouse and oxidative stress cell models[J].Nat Prod Commun,2021,16:1934578X20985346.
Bokhari R A,Lau S F,Mohamed S.Orthosiphon stamineus(misai kucing) ameliorated postmenopausal osteoporosis in rat model[J].Menopause,2018,25(2):202-210.
Wang L,Zhang X,Li Y X,et al.Aqueous extract of Clerodendranthus spicatus exerts protective effect on UV-induced photoaged mice skin[J].Evid Based Complement Alternat Med,2016,2016:9623957.
Wang X Q,Zhao W Q,Zhang X Y,et al.An integrative analysis to predict the active compounds and explore polypharmacological mechanisms of Orthosiphon stamineus Benth.[J].Comput Biol Med,2023,163:107160.
Wang Q R,Li N N,Wang Y J,et al.Studies on the key constituents and the related mechanisms of Clerodendranthus spicatus in the treatment of diabetes based on network pharmacology[J].J Ethnopharmacol,2023,303:115949.
Zhu C S,Niu H J,Nie A Z,et al.Bioactivity-guided separation of potential α-glycosidase inhibitor from Clerodendranthus spicatus based on HSCCC coupled with molecular docking[J].Sci Rep,2021,11(1):6914.
Maulana F,Muhammad A A,Umar A,et al.Profiling metabolites through chemometric analysis in Orthosiphon aristatus extracts as α-glucosidase inhibitory activity and in silico molecular docking[J].Indones J Chem,2021,22(1):501.
Li C,Lin D Y,Ouyang J T,et al.Integrative analyzing the molecular basis of Clerodendranthus spicatus aqueous extract in hyperuricemia nephropathy via network pharmacology and experimental validation[J].Food Biosci,2025,66:106152.
Pandaleke T A,Handono K,Widasmara D,et al.The immunomodulatory activity of Orthosiphon aristatus against atopic dermatitis:Evidence-based on network pharmacology and molecular simulations[J].J Taibah Univ Med Sci,2023,19(1):164-174.
Subbiah U,Ajith A,Venkata Subbiah H.Molecular docking and dynamics simulation of Orthosiphon stamineus against SGLT1 and SGLT2[J].J Biomol Struct Dyn,2023,41(23):13663-13678.
Su Y J,Li B,Liang W W,et al.The complete chloroplast genome of Orthosiphon aristatus (Blume) Miq.(Lamiaceae)[J].Mitochondrial DNA Part B,2024,9(1):79-82.
Du Q,Jiang M,Sun S H,et al.The complete chloroplast genome sequence of Clerodendranthus spicatus,a medicinal plant for preventing and treating kidney diseases from Lamiaceae family[J].Mol Biol Rep,2022,49(4):3073-3083.
Chen Y,Pei C Y,Chen Y,et al.Kidney tea ameliorates hyperuricemia in mice via altering gut microbiota and restoring metabolic profile[J].Chem Biol Interact,2023,376:110449.
Zhu C S,Niu H J,Bian M,et al.Study on the mechanism of Orthosiphon aristatus (Blume) Miq.in the treatment of hyperuricemia by microbiome combined with metabonomics[J].J Ethnopharmacol,2023,317:116805.
Luo Y,Liu Y,Wen Q,et al.Comprehensive chemical and metabolic profiling of anti-hyperglycemic active fraction from Clerodendranthi Spicati Herba[J].J Sep Sci,2021,44(9):1805-1814.
Ahmad Azam A,Pariyani R,Ismail I S,et al.Urinary metabolomics study on the protective role of Orthosiphon stamineus in Streptozotocin induced diabetes mellitus in rats via 1H NMR spectroscopy[J].BMC Complement Altern Med,2017,17(1):278.
Wang Q X,Long H,Liu S M,et al.Comparative transcriptome analyses of different Orthosiphon aristatus tissues reveal differentially expressed genes associated with flavonoid biosynthesis[J].Sci Rep,2025,15:1059.
廖宏亮,郭云涛,唐帅男,等.猫须草总黄酮对人肾透明细胞癌786-O细胞凋亡的影响及转录组学分析[J].上海中医药大学学报,2023,37(3):48-56.
Ramachandran H,Rahmat Z.Antioxidant analysis of protein from fresh and dry leaf of Orthosiphon aristatus(Blume) Miq.[J].Plant Sci Today,2024,11(4):323-329.
陈志侠,陈卫英,韩子华,等.血尿安胶囊联合体外冲击波碎石对输尿管结石的疗效分析[J].中国中西医结合肾病杂志,2022,23(11):1004-1005.
石晓欣,昌菁,王瑞良.肾安胶囊合并瑞舒伐他汀钙片对老年早期糖尿病肾病干预研究[J].辽宁中医药大学学报,2019,21(12):202-205.
金丽霞,金丽军,宋立群,等.虫草益肾颗粒联合促红细胞生成素治疗肾性贫血的疗效比较[J].中国临床保健杂志,2017,20(2):192-194.
Tamanna I S,Gayathri R,Sankaran K,et al.Eco-friendly synthesis of selenium nanoparticles using Orthosiphon stamineus leaf extract and its biocompatibility studies[J].Bio Nano Science,2024,14(1):37-44.
Seetharaman P K,Bo L,Sivapunniyam A,et al.Sustainable biofabrication and structural characterization of Zn O nanoparticles using terpene-rich fraction from Orthosiphon aristatus extract:Insights into biomedical and environmental applications[J].J Mol Struct,2025,1340:142489.

2026年第57卷第9期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.09.020

接收时间：2025-11-13
首发时间：2026-09-09

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-11-13

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.09.020

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT